Top Markets
Coin of the day
Q-linea AB (publ) Q-linea AB (publ)

Q-linea AB (publ)

QLINEA
Rank in Stocks #31264
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in... Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Share Price
$2.09
Market Cap
$13.95M
Change (1 day)
7.76%
Change (1 year)
-62.23%
Country
SE
Trade Q-linea AB (publ) (QLINEA)

Category

P/B ratio for Q-linea AB (publ) (QLINEA)
P/B ratio as of 2026 TTM: 0
According to Q-linea AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Q-linea AB (publ) from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
7.6976 -
US
1.9116 -
FR
- -
JP
2.0641 -
US
- -
CH